by Rod Raynovich | Oct 20, 2010 | 2023-24 Life Science Portfolios, BIOgraph
Risk is on today due to a weak dollar and that is usually good for Life Science stocks.MidCap biotechs are mainly green despite bad news from Amylin (AMLN) $11.35 down 44%, and partner Alkermes (ALKS) $10.91 down 24.75% a setback on their long- acting drug for...